Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Identification of Native and Posttranslationally Modified HLA-B*57:01-Restricted HIV Envelope Derived Epitopes Using Immunoproteomics.

Ramarathinam SH, Gras S, Alcantara S, Yeung AWS, Mifsud NA, Sonza S, Illing PT, Glaros EN, Center RJ, Thomas SR, Kent SJ, Ternette N, Purcell DFJ, Rossjohn J, Purcell AW.

Proteomics. 2018 Jun;18(12):e1700253. doi: 10.1002/pmic.201700253. Epub 2018 Apr 10.

PMID:
29437277
2.

Increasing prevalence of K65K and K66K in HIV-1 subtype B reverse transcriptase.

Telwatte S, Brumme CJ, Hearps AC, Latham CF, Hayward JA, Sonza S, Sluis-Cremer N, Harrigan PR, Tachedjian G.

AIDS. 2016 Nov 28;30(18):2787-2793.

PMID:
27677159
3.

MYB elongation is regulated by the nucleic acid binding of NFκB p50 to the intronic stem-loop region.

Pereira LA, Hugo HJ, Malaterre J, Huiling X, Sonza S, Cures A, Purcell DF, Ramsland PA, Gerondakis S, Gonda TJ, Ramsay RG.

PLoS One. 2015 Apr 8;10(4):e0122919. doi: 10.1371/journal.pone.0122919. eCollection 2015.

4.

Silent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations.

Telwatte S, Hearps AC, Johnson A, Latham CF, Moore K, Agius P, Tachedjian M, Sonza S, Sluis-Cremer N, Harrigan PR, Tachedjian G.

Nucleic Acids Res. 2015 Mar 31;43(6):3256-71. doi: 10.1093/nar/gkv128. Epub 2015 Mar 12.

5.

Vaginal concentrations of lactic acid potently inactivate HIV.

Aldunate M, Tyssen D, Johnson A, Zakir T, Sonza S, Moench T, Cone R, Tachedjian G.

J Antimicrob Chemother. 2013 Sep;68(9):2015-25. doi: 10.1093/jac/dkt156. Epub 2013 May 8.

6.

Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions.

Henriques ST, Huang YH, Castanho MA, Bagatolli LA, Sonza S, Tachedjian G, Daly NL, Craik DJ.

J Biol Chem. 2012 Sep 28;287(40):33629-43. Epub 2012 Aug 1.

7.

SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.

Price CF, Tyssen D, Sonza S, Davie A, Evans S, Lewis GR, Xia S, Spelman T, Hodsman P, Moench TR, Humberstone A, Paull JR, Tachedjian G.

PLoS One. 2011;6(9):e24095. doi: 10.1371/journal.pone.0024095. Epub 2011 Sep 15.

8.

Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.

Henriques ST, Huang YH, Rosengren KJ, Franquelim HG, Carvalho FA, Johnson A, Sonza S, Tachedjian G, Castanho MA, Daly NL, Craik DJ.

J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16.

9.

Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1.

Telwatte S, Moore K, Johnson A, Tyssen D, Sterjovski J, Aldunate M, Gorry PR, Ramsland PA, Lewis GR, Paull JR, Sonza S, Tachedjian G.

Antiviral Res. 2011 Jun;90(3):195-9. doi: 10.1016/j.antiviral.2011.03.186. Epub 2011 Apr 1.

10.

Structure activity relationship of dendrimer microbicides with dual action antiviral activity.

Tyssen D, Henderson SA, Johnson A, Sterjovski J, Moore K, La J, Zanin M, Sonza S, Karellas P, Giannis MP, Krippner G, Wesselingh S, McCarthy T, Gorry PR, Ramsland PA, Cone R, Paull JR, Lewis GR, Tachedjian G.

PLoS One. 2010 Aug 23;5(8):e12309. doi: 10.1371/journal.pone.0012309.

11.

N348I in HIV-1 reverse transcriptase decreases susceptibility to tenofovir and etravirine in combination with other resistance mutations.

Sluis-Cremer N, Moore K, Radzio J, Sonza S, Tachedjian G.

AIDS. 2010 Jan 16;24(2):317-9. doi: 10.1097/QAD.0b013e3283315697.

12.

Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides.

Sonza S, Johnson A, Tyssen D, Spelman T, Lewis GR, Paull JR, Tachedjian G.

Antimicrob Agents Chemother. 2009 Aug;53(8):3565-8. doi: 10.1128/AAC.00102-09. Epub 2009 Jun 15.

13.

HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages.

Dowling D, Nasr-Esfahani S, Tan CH, O'Brien K, Howard JL, Jans DA, Purcell DF, Stoltzfus CM, Sonza S.

Retrovirology. 2008 Feb 4;5:18. doi: 10.1186/1742-4690-5-18.

14.

Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription.

Jones KL, Sonza S, Mak J.

Nucleic Acids Res. 2008 Mar;36(5):1578-88. doi: 10.1093/nar/gkm1149. Epub 2008 Jan 23.

15.

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.

Sterjovski J, Churchill MJ, Ellett A, Gray LR, Roche MJ, Dunfee RL, Purcell DF, Saksena N, Wang B, Sonza S, Wesselingh SL, Karlsson I, Fenyo EM, Gabuzda D, Cunningham AL, Gorry PR.

Retrovirology. 2007 Dec 12;4:89.

16.

CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection.

Jaworowski A, Kamwendo DD, Ellery P, Sonza S, Mwapasa V, Tadesse E, Molyneux ME, Rogerson SJ, Meshnick SR, Crowe SM.

J Infect Dis. 2007 Jul 1;196(1):38-42. Epub 2007 May 16.

PMID:
17538881
17.

The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo.

Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, Sonza S, Crowe SM.

J Immunol. 2007 May 15;178(10):6581-9.

18.

SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication.

Darnell GA, Schroder WA, Gardner J, Harrich D, Yu H, Medcalf RL, Warrilow D, Antalis TM, Sonza S, Suhrbier A.

J Biol Chem. 2006 Oct 20;281(42):31348-58. Epub 2006 Aug 21.

19.

Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues.

Churchill MJ, Gorry PR, Cowley D, Lal L, Sonza S, Purcell DF, Thompson KA, Gabuzda D, McArthur JC, Pardo CA, Wesselingh SL.

J Neurovirol. 2006 Apr;12(2):146-52.

PMID:
16798676
20.

Normal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients.

Jaworowski A, Ellery P, Maslin CL, Naim E, Heinlein AC, Ryan CE, Paukovics G, Hocking J, Sonza S, Crowe SM.

J Infect Dis. 2006 Mar 1;193(5):693-7. Epub 2006 Jan 31.

PMID:
16453265
21.

Isolation of human immunodeficiency virus type 1 from peripheral blood monocytes.

Gorry PR, Sonza S, Kedzierska K, Crowe SM.

Methods Mol Biol. 2005;304:25-33.

PMID:
16061964
23.

Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription.

Bentley K, Deacon N, Sonza S, Zeichner S, Churchill M.

Arch Virol. 2004 Dec;149(12):2277-94. Epub 2004 Aug 30.

PMID:
15338321
24.

Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.

Sonza S, Mutimer HP, O'Brien K, Ellery P, Howard JL, Axelrod JH, Deacon NJ, Crowe SM, Purcell DF.

J Virol. 2002 Dec;76(24):12611-21.

25.

Reservoirs for HIV infection and their persistence in the face of undetectable viral load.

Sonza S, Crowe SM.

AIDS Patient Care STDS. 2001 Oct;15(10):511-8. Review. No abstract available.

PMID:
11689138
26.

Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

Sonza S, Mutimer HP, Oelrichs R, Jardine D, Harvey K, Dunne A, Purcell DF, Birch C, Crowe SM.

AIDS. 2001 Jan 5;15(1):17-22.

PMID:
11192864
27.

Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages.

Kedzierska K, Maerz A, Warby T, Jaworowski A, Chan H, Mak J, Sonza S, Lopez A, Crowe S.

AIDS. 2000 Aug 18;14(12):1739-48.

PMID:
10985310
29.

Specificity of binding of HIV-1 anti-p24 antibodies to CD4+ lymphocytes from HIV-infected subjects.

Cameron PU, Hunter SD, Jolley D, Sonza S, Mijch A, Crowe SM.

Cytometry. 1998 Sep 1;33(1):83-8.

PMID:
9725562
30.

Pitfalls of processed pseudogenes in RT-PCR.

Mutimer H, Deacon N, Crowe S, Sonza S.

Biotechniques. 1998 Apr;24(4):585-8. No abstract available.

31.

HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals.

Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM.

AIDS. 1998 May 7;12(7):719-27.

PMID:
9619803
32.

Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages.

Lewin SR, Sonza S, Irving LB, McDonald CF, Mills J, Crowe SM.

AIDS Res Hum Retroviruses. 1996 Jul 1;12(10):877-83.

PMID:
8798972
33.
34.

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J.

Science. 1995 Nov 10;270(5238):988-91.

PMID:
7481804
35.

Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression.

Sonza S, Maerz A, Uren S, Violo A, Hunter S, Boyle W, Crowe S.

AIDS Res Hum Retroviruses. 1995 Jul;11(7):769-76.

PMID:
7546902
36.

Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7.

Lazdins I, Coulson BS, Kirkwood C, Dyall-Smith M, Masendycz PJ, Sonza S, Holmes IH.

Virology. 1995 May 10;209(1):80-9.

37.

Accumulation of unintegrated circular viral DNA in monocytes and growth-arrested T cells following infection with HIV-1.

Sonza S, Kiernan RE, Maerz AL, Deacon NJ, McPhee DA, Crowe SM.

J Leukoc Biol. 1994 Sep;56(3):289-93. Review.

PMID:
8083601
38.

HIV-1 infection of monocyte-derived macrophages reduces Fc and complement receptor expression.

Kent SJ, Stent G, Sonza S, Hunter SD, Crowe SM.

Clin Exp Immunol. 1994 Mar;95(3):450-4.

39.

Antibodies to gp41 and nef in otherwise HIV-negative homosexual man with Kaposi's sarcoma.

Bowden FJ, McPhee DA, Deacon NJ, Cumming SA, Doherty RR, Sonza S, Lucas CR, Crowe SM.

Lancet. 1991 Jun 1;337(8753):1313-4.

PMID:
1674298
40.
41.

Antigens of infectious laryngotracheitis herpesvirus defined by monoclonal antibodies.

York JJ, Sonza S, Brandon MR, Fahey KJ.

Arch Virol. 1990;115(3-4):147-62.

PMID:
2175588
42.

Immunogenic glycoproteins of infectious laryngotracheitis herpesvirus.

York JJ, Sonza S, Fahey KJ.

Virology. 1987 Dec;161(2):340-7.

PMID:
2825407
43.

Intracellular localization of rotaviral proteins.

Richardson SC, Mercer LE, Sonza S, Holmes IH.

Arch Virol. 1986;88(3-4):251-64.

PMID:
3010907
44.

Demonstration of an immunodominant neutralization site by analysis of antigenic variants of SA11 rotavirus.

Lazdins I, Sonza S, Dyall-Smith ML, Coulson BS, Holmes IH.

J Virol. 1985 Oct;56(1):317-9.

45.

The major surface glycoprotein of simian rotavirus (SA11) contains distinct epitopes.

Sonza S, Breschkin AM, Holmes IH.

Virology. 1984 Apr 30;134(2):318-27.

PMID:
6085822
46.

Derivation of neutralizing monoclonal antibodies against rotavirus.

Sonza S, Breschkin AM, Holmes IH.

J Virol. 1983 Mar;45(3):1143-6.

47.

Preparation and characterization of antisera to electrophoretically purified SA11 virus polypeptides.

Bastardo JW, McKimm-Breschkin JL, Sonza S, Mercer LD, Holmes IH.

Infect Immun. 1981 Dec;34(3):641-7.

48.

Coproantibody response to rotavirus infection.

Sonza S, Holmes IH.

Med J Aust. 1980 Nov 1;2(9):496-9.

PMID:
6259502
49.

Supplemental Content

Support Center